Verona Pharma PLC - ADR

General ticker "VRNA" information:

  • Sector: Health Care
  • Industry: Pharmaceuticals
  • Capitalization: $3.3B

Verona Pharma PLC - ADR follows the US Stock Market performance with the rate: 56.6%.

Estimated limits based on current volatility of 3.5%: low 42.34$, high 45.45$

Factors to consider:

  • Current price 171.2% above estimated high
  • Earnings for 9 months up through Q3 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [7.49$, 16.61$]
  • 2024-12-30 to 2025-12-30 estimated range: [4.91$, 11.48$]

Financial Metrics affecting the VRNA estimates:

  • Negative: Non-GAAP EPS, $ of -0.69 <= 0.10
  • Negative: Operating profit margin, % of -100 <= 1.03
  • Negative: negative Net income
  • Negative: Operating cash flow per share per price, % of -3.99 <= 2.35
  • Negative: 0 < Interest expense per share, $ of 0.03

Similar symbols

Short-term VRNA quotes

Long-term VRNA plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $40.00MM $0.46MM $0.00MM
Operating Expenses $113.31MM $76.21MM $67.57MM
Operating Income $-73.31MM $-75.75MM $-67.57MM
Non-Operating Income $17.73MM $7.30MM $13.67MM
Interest Expense $0.34MM $0.52MM $2.06MM
R&D Expense $79.41MM $49.28MM $17.28MM
Income(Loss) $-55.59MM $-68.45MM $-53.90MM
Taxes $-0.02MM $0.25MM $0.47MM
Profit(Loss) $-55.57MM $-68.70MM $-54.37MM
Stockholders Equity $148.00MM $230.47MM $249.28MM
Inventory $4.04MM $2.50MM $0.00MM
Assets $186.59MM $259.47MM $308.12MM
Operating Cash Flow $-33.25MM $-59.86MM $-50.22MM
Capital expenditure $0.01MM $0.03MM $0.00MM
Investing Cash Flow $-0.01MM $-0.03MM $0.00MM
Financing Cash Flow $-6.12MM $140.82MM $92.87MM
Earnings Per Share* $-0.94 $-1.04 $-0.54

* EPS are Split Adjusted, recent splits may be reflected with a delay.